Why the study?
Do insulin sensitization (metformin) and antiandrogenic therapy (flutamide) improve endothelial dysfunction in a female rat model of polycystic ovary syndrome?
Do insulin sensitization (metformin) and antiandrogenic therapy (flutamide) improve endothelial dysfunction in a female rat model of polycystic ovary syndrome?
In a rat model of PCOS, endothelial dysfunction is driven by hyperandrogenism and insulin resistance rather than weight gain, and can be reversed by metformin or flutamide.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating in PCOS rat models; leaves open translation to human endothelial dysfunction therapy.
This study was designed to differentiate the contributions of hyperandrogenism, insulin resistance (IR), and body weight to the development of endothelial dysfunction in polycystic ovary syndrome and determine the effectiveness of insulin sensitization and antiandrogenic therapy after the establishment of vascular and metabolic dysfunction using a rat model of polycystic ovary syndrome. We hypothesized that the observed endothelial dysfunction was a direct steroidal effect, as opposed to changes in insulin sensitivity or body weight. Prepubertal female rats were randomized to the implantation of a pellet containing DHT or sham procedure. In phase 1, DHT-exposed animals were randomized to pair feeding to prevent weight gain or metformin, an insulin-sensitizing agent, from 5 to 14 weeks. In phase 2, DHT-exposed animals were randomized to treatment with metformin or flutamide, a nonsteroidal androgen receptor blocker from 12 to 16 weeks. Endothelial function was assessed by the vasodilatory response of preconstricted arteries to acetylcholine. Serum steroid levels were analyzed in phase 1 animals. Fasting blood glucose and plasma insulin were analyzed and homeostasis model assessment index calculated in all animals. Our data confirm the presence of endothelial dysfunction as well as increased body weight, hypertension, hyperinsulinemia, and greater IR among DHT-treated animals. Even when normal weight was maintained through pair feeding, endothelial dysfunction, hyperinsulinemia, and IR still developed. Furthermore, despite weight gain, treatment with metformin and flutamide improved insulin sensitivity and blood pressure and restored normal endothelial function. Therefore, the observed endothelial dysfunction is most likely a direct result of hyperandrogenism-induced reductions in insulin sensitivity, as opposed to weight gain.
No takes yet. Share an insight, caveat, or question.
Hurliman et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: